Healthcare >> CEO Interviews >> October 12, 2001

Gregory Mossinghoff – Inspire Pharmaceuticals Inc (isph)

MARY BENNETT, Vice President, Operations and Communications, of Inspire Pharmaceuticals, Inc., joined the company in March 2001. She manages a variety of areas for Inspire, including Human Resources, Communications, Investor Relations and Operations. Mrs. Bennett comes to Inspire from Glaxo Wellcome, where she served as Worldwide Director for R&D Human Resources Effectiveness, Planning and Communication. Prior to her role in human resources, Mrs. Bennett held various roles during her 13 years at Glaxo Wellcome, including Worldwide Director for R&D Communications, Director of R&D Operations and Department Head of Comparative Medicine. She also led communications for major company redesign initiatives, and for the Glaxo Wellcome merger. Mrs. Bennett holds a BA in Behavioral Science from National-Louis University and an MBA from Duke University. Profile
GREGORY J. MOSSINGHOFF is Senior Vice President, Chief Business Officer, Secretary and Treasurer of Inspire Pharmaceuticals, Inc. He is also a member of the company's Board of Directors. Since joining the company in 1998, he has been responsible for all business-related activities, including corporate development, finance, strategic planning and operations. He has over 13 years of experience in the pharmaceutical industry. Prior to joining Inspire, Mr. Mossinghoff was worldwide Director of Business Analysis at Glaxo Wellcome Plc from 1995-1998. Before joining Glaxo Wellcome, Mr. Mossinghoff filled various positions of increasing responsibility in business development, new product planning, finance and operations at Roche Holding Ltd., Basel, Switzerland, and Nutley, NJ, from 1988 to 1995. Prior to entering the pharmaceutical industry, Mr. Mossinghoff was a stockbroker at Folger Nolan Fleming Douglas Inc., Washington, DC, and served the Committee on Science and Technology, US House of Representatives, as a Congressional Intern. Mr. Mossinghoff received a BA degree in Economics from the University of Virginia, Charlottesville, VA, and an MBA in Financial Management and Analysis from George Mason University, Fairfax, VA. He is a member of the Licensing Executives Society, National Association of Corporate Directors and Biotechnology Industry Association. Profile
TWST: Could we begin with a brief historical sketch and an overview of

Inspire Pharmaceuticals?

Mr. Mossinghoff: Inspire began operations in 1995, based on technology

that was licensed